Huake Holding Biology Past Earnings Performance

Past criteria checks 5/6

Huake Holding Biology has been growing earnings at an average annual rate of 15.7%, while the Food industry saw earnings growing at 12.1% annually. Revenues have been growing at an average rate of 18.2% per year. Huake Holding Biology's return on equity is 13.9%, and it has net margins of 13.7%.

Key information

15.7%

Earnings growth rate

15.7%

EPS growth rate

Food Industry Growth	16.0%
Revenue growth rate	18.2%
Return on equity	13.9%
Net Margin	13.7%
Last Earnings Update	31 Mar 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Huake Holding Biology makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqCM:HUAK Revenue, expenses and earnings (USD Millions)
Date	Revenue	Earnings	G+A Expenses
31 Mar 22	21	3	1
31 Dec 21	20	3	1
30 Sep 21	19	2	1
30 Jun 21	17	2	1
31 Mar 21	15	2	1
31 Dec 20	15	2	1
30 Sep 20	15	2	1
30 Jun 20	14	2	0
31 Mar 20	14	2	0
31 Dec 19	14	2	0
30 Sep 19	14	2	1
30 Sep 18	14	2	0

Quality Earnings: HUAK has high quality earnings.

Growing Profit Margin: HUAK's current net profit margins (13.7%) are higher than last year (10.9%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: HUAK's earnings have grown by 15.7% per year over the past 5 years.

Accelerating Growth: HUAK's earnings growth over the past year (80.6%) exceeds its 5-year average (15.7% per year).

Earnings vs Industry: HUAK earnings growth over the past year (80.6%) exceeded the Food industry -1%.

Return on Equity

High ROE: HUAK's Return on Equity (13.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/12/22 05:51
End of Day Share Price	2022/12/21 00:00
Earnings	2022/03/31
Annual Earnings	2021/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Huake Holding Biology Co., LTD. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution